Nanobac Pharmaceuticals

Our objective is to develop methods to treat Calcifying Nanoparticles (CNPs), and by so doing find more effective approaches to the diseases associated with them.
Pharmaceutical Drug Discovery
Our drug discovery and development efforts focus on new and existing compounds that effectively inhibit, destroy or neutralize CNPs.We are narrowly focused on new combinations of well-known drugs that have been shown to eradicate CNPs.Our business strategy is to develop and license compounds to address unmet needs of patients in the cardiovascular and urological disease markets.

Contact Details: 4730 North Habana Suite 205 Villeurbanne Florida 33614 United States of America Tel: (813) 264-2241 Fax: (813) 264-5512 Email: info@nanobaclabs.com WWW: www.nanobac.com/

Loading...

Recent Publications by Nanobac Pharmaceuticals:
Do blood-borne calcifying nanoparticles self-propagate? The nanotechnology industry is currently in the process of producing new...	17th September, 2008	Nanobac Pharmaceuticals Inc, Johnson Space Center, Houston,TX 77058, USA.	Int J Nanomedicine. 2008;3(2):265-75.
Association between Randall's plaque and calcifying nanoparticles. OBJECTIVES: Randall initially described calcified subepithelial papillary...	20th June, 2008	Nanobac Pharmaceuticals, Johnson Space Center, Houston, TX, USA.	Int J Nanomedicine. 2008;3(1):105-15.
Nanobacteria: fact or fiction? Characteristics, detection, and medical importance of novel self-replicating, calcifying nanoparticles. OBJECTIVES: Randall initially described calcified subepithelial papillary...	21st February, 2007	Nanobac Pharmaceuticals Inc., NASA Johnson Space Center, Houston, TX	J Investig Med. 2006 Nov;54(7):385-94.

BioNews Results for Nanobac Pharmaceuticals:
Angiotech Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 5:28AM Matching: pharmaceuticals
Auxilium Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 4:32AM Matching: pharmaceuticals
Achillion Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 7:22AM Matching: pharmaceuticals
Altus Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 5:52AM Matching: pharmaceuticals
Poniard Pharmaceuticals to Host Conference Call and Webcast at 8:00 a.m. Eastern Time Tomorrow to Discuss Results of Pivotal Phase 3 SPEAR Trial in Small Cell Lung Cancer	FinanzNachrichten.de:  Nov 16 2009 12:34AM Matching: pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more Nanobac Pharmaceuticals news.

Nanobac Pharmaceuticals (NNBPE.OB) Financial information Links from Barchart
NNBPE.OB Quote from from Barchart.com
NNBPE.OB Chart from from Barchart.com
NNBPE.OB Profile from from Barchart.com
NNBPE.OB Opinion from from Barchart.com
→View more Nanobac Pharmaceuticals finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 279 times since April 2007, the link to the organisation's website has been followed 46 times

Search for more companies in Villeurbanne

Search for more companies in Florida

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Nanobac Pharmaceuticals